The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Long-term (LT) disease-free survival (DFS) of melanoma (MM) and renal cell cancer (RCC) patients following high-dose interleukin-2 (HD IL2).
 
Joseph Clark
Employment - Bristol-Myers Squibb (I)
Consulting or Advisory Role - Exelixis
Speakers' Bureau - Bristol-Myers Squibb; Merck
Research Funding - Argos Therapeutics (Inst); AVEO (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Prometheus (Inst)
Travel, Accommodations, Expenses - Genentech/Roche; Genentech/Roche (I)
 
Brendan D. Curti
Honoraria - Prometheus
Speakers' Bureau - Bristol-Myers Squibb; Prometheus
Research Funding - Bristol-Myers Squibb (Inst); MedImmune (Inst); Prometheus (Inst); Viralytics (Inst)
Travel, Accommodations, Expenses - Agonox; Prometheus
 
Elizabeth J. Davis
No Relationships to Disclose
 
Howard Kaufman
Employment - Compass Therapeutics
Leadership - Compass Therapeutics
Honoraria - Amgen; Celldex; EMD Serono; Merck; Prometheus; Turnstone Bio
Consulting or Advisory Role - Amgen; Celldex; Merck; Merck Serono; Prometheus; Turnstone Bio
Speakers' Bureau - Merck
Research Funding - Amgen (Inst); Merck (Inst)
Travel, Accommodations, Expenses - EMD Serono; Turnstone Bio
 
Asim Amin
Consulting or Advisory Role - Merck
Speakers' Bureau - Bristol-Myers Squibb; Merck; Pfizer
Research Funding - Bristol-Myers Squibb; Merck
 
Ajjai Shivaram Alva
Consulting or Advisory Role - AstraZeneca; Eisai; Roche
Speakers' Bureau - AstraZeneca
Research Funding - Acerta Pharma (Inst); ARIAD (Inst); AstraZeneca (Inst); Bayer (Inst); BIND Biosciences (Inst); BIND Biosciences (Inst); Bristol-Myers Squibb (Inst); Covance (Inst); Genentech (Inst); Hoosier Cancer Research Network (Inst); Merck Sharp & Dohme (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Prometheus (Inst); Roche (Inst); United Biosource Corporation (Inst)
 
Douglas Buckner Johnson
Consulting or Advisory Role - Bristol-Myers Squibb; Genoptix
Research Funding - Incyte
 
Richard L. White
No Relationships to Disclose
 
Peter H. Wiernik
Honoraria - Novartis; TRACON Pharma
Travel, Accommodations, Expenses - Novartis
 
Janice P. Dutcher
Consulting or Advisory Role - Bristol-Myers Squibb/Medarex; Nektar; Novartis; Prometheus; TRACON Pharma
Speakers' Bureau - Exelixis; Novartis; Prometheus
Travel, Accommodations, Expenses - Novartis; Prometheus